ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Pediatric rheumatology"

  • Abstract Number: 0390 • ACR Convergence 2025

    Radiographic Assessment in Juvenile Spondyloarthritis: Evaluating the axJSpA Criteria Using Radiographs Alone Versus MRI

    David M. Biko1, Nancy A. Chauvin2, Michael Francavilla3, Nele Herregods4, Walter P. Maksymowych5, Robert G. W. Lambert6, Timothy Brandon1, Ozgur Kasapcopur7, Mehmet YILDIZ8, Hemalatha Srinivasalu9 and Pamela Weiss10, 1Children's Hospital of Philadelphia, Philadelphia, PA, 2The Cleveland Clinic, Hummelstown, PA, 3Department of Pediatric Radiology, Children’s Hospital Philadelphia, Philadelphia, PA, 4Ghent University Hospital, Ghent, Belgium, 5Department of Medicine, University of Alberta, 568 Heritage Building, Edmonton, AB, Canada, 6University of Alberta, Department of Radiology & Diagnostic Imaging, Edmonton, AB, Canada, 7Istanbul University-Cerrahpasa, Cerrahpasa Medical School, istanbul, Turkey, 8Istanbul University-Cerrahpasa Department of Pediatric Rheumatology, Istanbul, Turkey, 9Children's National Hospital, Washington, DC, 10Childrens Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Radiographs are neither sensitive nor reliable for assessing axial disease in juvenile spondyloarthritis (JSpA), though they are still used in some settings due to…
  • Abstract Number: 2301 • ACR Convergence 2025

    Use of lived experiences in childhood Sjogren Disease to develop outcome measures for an N-of-1 treatment trial.

    Sara M. Stern1, Angela Merritt2, Ludovic Trinquart3, Emma Barnboym4, Michelle LeeBravatti3, Suzy Richins5, Tressie L. Rollins5, Hanna M. Salzman5, Marisha Palm3, Cortney M. Wieber6, Hermine Brunner7 and Nora G. Singer8, 1University of Utah, Salt Lake City, UT, 2Cincinnati Childrens Hospital Medical Center, Cincinnati, OH, 3Tufts University School of Medicine, Boston, MA, 4The MetroHealth System at Case Western Reserve University School of Medcine, Cleveland, OH, 5Pediatric Rheumatology, University of Utah, Salt Lake City, UT, 6Institute for Clinical Research and Health Policy Studies (ICRHPS) and CTSI, Tufts School of Medicine, Boston, MA, 7Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 8The MetroHealth System at Case Western Reserve University School of Medicine, Cleveland, OH

    Background/Purpose: Childhood Sjogren Disease (cSjD) is a rare disease that presents with a wide variety of symptoms. Compared to adult SjD, cSjD more frequently manifests…
  • Abstract Number: 2148 • ACR Convergence 2025

    Initial MRI Findings as Predictors of Disease Phenotype in Juvenile Dermatomyositis: A Comparative Study of Myositis Specific Antibodies NXP2-Positive and Myositis Specific Antibody-Negative Patients in a Large Tertiary Hospital

    Juan Torres Sanchez1, Pritish Bawa2, Andrea Ramirez1, MaiLan Nguyen3, Amit Thakral4, Xiaofan Huang1, J Herman Kan2 and Marietta De Guzman1, 1Baylor College of Medicine, Houston, TX, 2Texas Childrens Hospital, Houston, TX, 3Baylor College of Medicine, Austin, TX, 4Texas Children’s Hospital, Houston, TX

    Background/Purpose: Juvenile dermatomyositis (JDM) is the most common idiopathic inflammatory myopathy of childhood, characterized by proximal muscle weakness and distinctive cutaneous findings. Magnetic resonance imaging…
  • Abstract Number: 2124 • ACR Convergence 2025

    Reliability and Validation of the Physician’s Global Assessment of Lung Disease (PGALD) in Systemic Juvenile Idiopathic Arthritis -Associated Lung Disease (SJIA-LD)

    Eileen Rife1, Guihua Zhai2, Mekibib Altaye3, Jennifer Andringa4, Hermine Brunner5, Scott Canna6, Lauren Henderson7, Yukiko Kimura8, Scott Lieberman9, Mona Riskalla10, Tiphanie Vogel11, Holly Wobma12 and Grant Schulert5, 1University of Alabama at Birmingham, birmingham, AL, 2UAB, Birmingham, 3Cincinnati Children's Hospital, Cincinnati, 4Cincinnati Children's Hospital Medical Center, Cincinnati, 5Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 6Children's Hospital of Philadelphia, Philadelphia, PA, 7Boston Children's Hospital, Watertown, MA, 8Hackensack Meridian School of Medicine, New York, NY, 9University of Iowa, Iowa City, IA, 10University of Minnesota Masonic Children's Hospital, Minneapolis, MN, 11Baylor College of Medicine, Houston, TX, 12Boston Children's Hospital, Boston, MA

    Background/Purpose: The physician global assessment of lung disease (PGALD) is a recently proposed disease activity measure for patients with systemic juvenile idiopathic arthritis-associated lung disease…
  • Abstract Number: 1745 • ACR Convergence 2025

    High Emotional Distress Predicts Suboptimal Cardiovascular Health Among Patients with Juvenile-Onset Lupus and Dermatomyositis: Longitudinal Analysis of the Lupus Erythematosus and Dermatomyositis Stress and Cardiovascular Health Cohort Study

    Kaveh Ardalan1, Angel Davalos1, Hwanhee Hong1, Bryce Reeve1, Christoph Hornik1, M. Anthony Moody1, Donald Lloyd-Jones2, Eveline Wu3, Audrey Ward4, Simisola Gbadegesin5, Rebecca Sadun6, Jeffrey Dvergsten7, Lauren Covert1, Ann Reed1, Mark Connelly8 and Laura Schanberg9, 1Duke University School of Medicine, Durham, NC, 2Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 3UNC Chapel Hill, Chapel Hill, NC, 4Children's National Hospital, Washington, DC, 5Wake Forest University School of Medicine, Winston-Salem, NC, 6Duke University, Durham, NC, 7Duke University Hospital, Hillsborough, NC, 8Children’s Mercy Kansas City/University of Missouri-Kansas City School of Medicine, Kansas City, MO, 9Duke University Medical Center, DURHAM, NC

    Background/Purpose: Juvenile lupus & dermatomyositis (JSLE/JDM) patients experience high emotional distress and premature loss of cardiovascular health (CVH), defined as protective factors against cardiovascular disease…
  • Abstract Number: 1494 • ACR Convergence 2025

    Comparing Childhood-Onset Versus Adult-Onset Systemic Lupus Erythematosus Young Adults’ Lived Employment Experiences

    NILOFAR JAHAGHI1, Michael Golding2, Fareha Nishat3, Kaitlyn Merrill2, Diane Lacaille4, Umut Oguzoglu2, Roberta Woodgate2, Jennifer Stinson5, Christine Peschken6, Zahi Touma7, Jennifer Protudjer2 and Lily Lim6, 1Karolinska Institutet, Stockholm, Sweden, 2University of Manitoba, Winnipeg, Canada, 3University of Toronto, Toronto, Canada, 4Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada, 5The Hospital for Sick Children, Toronto, ON, Canada, 6University of Manitoba, Winnipeg, MB, Canada, 7University of Toronto, Toronto, ON, Canada

    Background/Purpose: Young adulthood (18-30 years) is a life stage with many transitions. Young adults with Systemic Lupus Erythematosus must navigate this period while living with…
  • Abstract Number: 1288 • ACR Convergence 2025

    Is gastroesophageal reflux a risk for interstitial lung disease in Juvenile systemic sclerosis?

    Ivan Foeldvari1, Kathryn Torok2, Ozgur Kasapcopur3, Amra Adrovic4, Brian Feldman5, Flavio Sztajnbok6, Maria Teresa Terreri7, Ana Sakamoto8, Jordi Anton9, Sindhu Johnson10, Raju Khubchandani11, Valda Stanevica12, Gülcan Özomay Baykal13, Dieneke Schonenberg-Meinema14, Eslam Al-Abadi15, Ekaterina Alexeeva16, Maria Katsicas17, Sujata Sawhney18, Vanessa Smith19, Sima Abu Alsaoud20, Simone Appenzeller21, Tadej Avcin22, Natalia Cabrera23, Stefanie Hajek24, Siri Opsahl Hetlevik25, Mikhail Kostik26, Thomas Lehman27, Suzanne Li28, Hana Malcova29, Edoardo Marrani30, Clare Pain31, Anjali Patwardhan32, Walter Alberto Sifuentes-Giraldo33, Natalia Vasquez-Canizares34, Patricia Costa Reis35, Mahesh Janarthanan36, Maria Jose Santos37, Cristina Battagliotti38, Lillemor Berntson39, blanca e r bica40, Jürgen Brunner41, Liora Harel42, Gerd Horneff43, Daniela Kaiser44, Jorge Lopez-Benitez45, Farzana Nuruzzaman46, Mihaela Sparchez47, Yosef Uziel48 and Nicola Helmus49, 1Hamburger Zentrum für Kinder- und Jugendrheumatologie, Hamburg, Germany, 2University of Pittsburgh, Pittsburgh, PA, 3Istanbul University-Cerrahpasa, Cerrahpasa Medical School, istanbul, Turkey, 4Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Turkey, Turkey, 5The Hospital for Sick Children, Toronto, ON, Canada, 6UFRJ/UERJ, SAO PAULO, Brazil, 7UNIFESP, São Paulo, São Paulo, Brazil, 8Federal University of São Paulo (UNIFESP), São Paulo, São Paulo, Brazil, 9Hospital Sant Joan de Düu. Universitat de Barcelona, Esplugues de Llobregat (Barcelona), Spain, 10Division of Rheumatology, Department of Medicine, Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western and Mount Sinai Hospitals; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada, 11Jaslok Hospital and Research Center, Mumbai, India, 12Childrens Clinical University Hospital, Zemgales priekšpilseta, Riga, Latvia, 13Umraniye Training and Research Hospital, Istanbul, Turkey, 14Emma Children’s Hospital, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands, 15Birmingham Women’s and Children’s Hospital NHSFT, Birmingham, United Kingdom, 16National Medical Research Center for Children’s Health Federal State Autonomous Institution of the Russian Federation Ministry of Health and I.M. Sechenov First Moscow State Medical University (Sechenovskiy University), Moscow, Russia, 17Hospital Garrahan, Buenos Aires, Argentina, 18Sir Ganga Ram Hospital, Sector 37 noida, Uttar Pradesh, India, 19Ghent University Hospital, Gent, Belgium, 20Caritas baby Hospital, Jerusalem, Palestine, 21Unicamp, Campinas, São Paulo, Brazil, 22University Children's Hospital University Medical Center Ljubljana, Ljubljana, Slovenia, 23IPS Central: Asunción, Asuncion, Paraguay, 24Deutsches Zentrum für Kinder- und Jugendrheumatologie, Garmisch-Partenkirchen, Germany, 25Oslo University Hospital, Oslo, Norway, 26Saint-Petersburg State Pediatric Medical University, Saint Petersburg, Russia, 27Hospital for Special Surgery, New York, 28Joseph M. Sanzari Children's Hospital and Hackensack Meridian School of Medicine, Hackensack, NJ, 29Motol University Hospital, Prague, Czech Republic, 30Meyer Children Hospital IRCCS, Firenze, Italy, 31Alder Hey NHS Trust, Liverpool, United Kingdom, 32University of Missouri-Columbia, Columbia, MO, 33Hospital Universitario Ramón y Cajal, Madrid, Spain, 34Children’s Hospital at Montefiore, Bronx, NY, 35Hospital de Santa Maria, Lisbon, Portugal, 36SRI RAMACHANDRA INSTITUTE OF HIGHER EDUCATION AND RESEARCH, Chennai, Tamil Nadu, India, 37Hospital Garcia de Orta, Almada, Lisboa, Portugal, 38Hospital de Niños Dr Orlando Alassia, Santa Fe, Argentina, 39Dept. of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden, 40UNIVERSIDADE FEDERAL DO RIO DE JANEIRO, Rio de Janeiro, Brazil, 41Medical University Innsbruck; Department of Pediatrics, Pediatric Rheumatology, Innsbruck, Austria, 42Schneider Children's Medical center, Nettnja, Israel, 43Asklepios Klinik, Hamburg, Germany, 44Childrens Hospital Lucerne, Lucerne, Switzerland, 45Private Practice, Asuncion, Paraguay, 46Stony Brook Children's Hospital, Stony Brook, NY, 47Emergency Clinical Hospital for Children, Cluj-Napoca, Romania, 48Pediatric Rheumatology Unit, Meir Medical Center, Kfar Saba, Sackler School of Medicine, Tel Aviv University, Kfar Saba, Israel, 49Hamburg Centre for Pediatric and Adolescence Rheumatology, Hamburg, Germany

    Background/Purpose: Gastroesophageal involvement, particularly reflux, has been identified as a risk factor for development and progression of interstitial lung disease (ILD) in adult systemic sclerosis…
  • Abstract Number: 1226 • ACR Convergence 2025

    Preliminary Findings in the Validation of the Modified Pain and Symptom Assessment Tool in Juvenile Fibromyalgia Syndrome

    Daniella Schocken1, Mark Connelly2, Sabrina Gmuca3, Andrea Ramirez4, Mary Ellen Riordan5, Tracy Ting6, Susmita Kashikar-Zuck7 and Jennifer Weiss8, 1Children's Mercy Kansas City, Tampa, FL, 2Children’s Mercy Kansas City/University of Missouri-Kansas City School of Medicine, Kansas City, MO, 3Children's Hospital of Philadelphia, Philadelphia, PA, 4Baylor College of Medicine, Houston, TX, 5Hackensack University Medical Center, Hackensack, NJ, 6Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 7University of Cincinnati College of Medicine; Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 8Joseph M. Sanzari Children's Hospital and Hackensack Meridian School of Medicine, Hackensack, NJ

    Background/Purpose: Diagnosing juvenile fibromyalgia (JFM) in youth with chronic musculoskeletal (MSK) pain is challenging in the absence of a validated diagnostic tool. The Pain and…
  • Abstract Number: 0419 • ACR Convergence 2025

    Ultrasound-Guided Synovial Biopsy in Children and Adolescents with Juvenile Arthritis: Initial Results

    Patricia Vega-Fernandez1, Kelly Rogers2, Megan Quinlan-Waters3, Sheila Angeles-Han2, Alexei Grom1, Daniel Lovell1, Jennifer Huggins4, Ekemini Ogbu1, Amy Cassedy5, Sara Szabo1, Tracy Ting1, Grant Schulert1, McKenzie Vater6, Hermine Brunner1, Jackeline Rodriguez-Smith1 and Katelyn Banschbach7, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Cincinnati Children's Hospital, Cincinnati, OH, 3Cincinnati Children's Hospital Medical Center, CCHMC, 4Cincinnati Children's Medical Center, Cincinnati, OH, 5Cincinnati Children's hospital medical center, cincinnati, OH, 6Cincinnati Children's Hospital Medical Center, Fort Thomas, KY, 7cincinnati Children's hospital, Villa Hills, KY

    Background/Purpose: Ultrasound-guided synovial biopsy (USGSB) has been recently implemented for clinical and research purposes in adults with inflammatory arthritis. The current use of USGSB in…
  • Abstract Number: 0388 • ACR Convergence 2025

    A Scoping Review of Outcomes of Adults With Childhood-Onset Systemic Autoimmune Rheumatic Diseases

    Michael Moore1, Kaien Gu2, Carol Cooke1, Annaliese Tisseverasinghe1 and Lily Lim1, 1University of Manitoba, Winnipeg, MB, Canada, 2Feinstein Institutes for Medical Research, Manhasset, NY

    Background/Purpose: Systemic autoimmune rheumatic diseases (SARD) include systemic lupus erythematous (SLE), idiopathic inflammatory myositis (IIM), systemic sclerosis (SSc), Sjögren syndrome (SS), and systemic vasculitis (SV).…
  • Abstract Number: 2206 • ACR Convergence 2025

    Adolescents with Systemic Lupus Erythematosus at Highest Risk of Adverse Pregnancy Outcomes

    Catherine Deffendall1, Sarah Green2, Ashley Suh2, Bryan Han2 and April Barnado2, 1Vanderbilt University, Nashville, TN, 2Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Few studies exist that examine pregnancy outcomes in adolescents with SLE. To our knowledge, there have been no studies comparing SLE adolescent pregnancies to…
  • Abstract Number: 2147 • ACR Convergence 2025

    Elevated fMET and GDF-15 Circulating Levels in Pediatric CNO Patients with Psoriasis Define a Distinct Mitochondrial-Inflammatory Signature

    Arpit Rathee1, Noor Kaur1, Jorge A. Gonzalez-Chapa2, Ryan D. Stultz1, Emily Deng3, Ian Muse4, Yongdong Zhao3 and Christian Lood2, 1University of Washington, Division of Rheumatology, Seattle, WA, 2University of Washington, Division of Rheumatology, Seattle, 3University of Washington, Department of Pediatrics, Seattle Children's Hospital, Seattle, WA, 4University of Washington, Department of Pediatrics, Seattle Children's Hospital, Seattle

    Background/Purpose: Chronic nonbacterial osteomyelitis (CNO) is a pediatric autoinflammatory bone disorder marked by sterile skeletal inflammation. A subset of CNO patients presents with comorbid psoriasis,…
  • Abstract Number: 1989 • ACR Convergence 2025

    Moving Out of the Kid’s Rheum: Transitioning Young Adult Patients from Pediatric to Adult Rheumatology Practices

    Victoria Koenigsberger1, Madeleine Ward2, Meghan Geary3 and Ali Yalcindag4, 1The Warren Alpert Medical School of Brown University, Providence, RI, 2The Warren Alpert Medical School of Brown University, Division of Medicine-Pediatrics, Providence, 3The Warren Alpert Medical School of Brown University, Division of General Internal Medicine, Providence, 4The Warren Alpert Medical School of Brown University, Division of Rheumatology, Department of Pediatrics, Milton, MA

    Background/Purpose: Young adults with childhood-onset rheumatic conditions encounter challenges and barriers to care when transitioning to an adult rheumatologist. At this Pediatric Rheumatology Clinic, patients…
  • Abstract Number: 1743 • ACR Convergence 2025

    Comparative assessment of cardiovascular risk and its predictors in a large cohort of young adults with juvenile systemic lupus erythematosus and juvenile dermatomyositis

    Jiangning Li, Shreya Doddi, Tharuni Mailoo and Coziana Ciurtin, University College London, London, United Kingdom

    Background/Purpose: Juvenile systemic lupus erythematosus (JSLE) and juvenile dermatomyositis (JDM) are associated with chronic inflammation that can accelerate atherosclerosis. There is no specific guidance regarding…
  • Abstract Number: 1304 • ACR Convergence 2025

    The role of PET/CT in evaluating rheumatologic conditions in children with fever of unknown origin – a multicenter study

    Neta Berlak1, Lydia Christodoulou2, Gil Amarilyo3, Oded Scheuerman4, Irit Tirosh5, Eyal Kristal6, Ester Forer7, Amit Carmi8, Alon Kalter9 and Yoel Levinsky10, 1Schneider children's medical center of Israel, Tel Aviv, Israel, 2Tel Hashomer, Periatric rheumatology unit, Tel Aviv, Israel, 3Schneider Children's Medical Center of Israel, Kibbutz Maggal, Israel, 4schneider children's meidcal center of Israel, Petah tikva, Israel, 5Tel Aviv universty, Ramat Gan, Israel, 6Soroka medical center Beer Sheva, Beer Sheva, Israel, 7Soroka medical center, Beer Sheva, Israel, 8Schneider children's meidcal center of Israel, Tel Aviv, Israel, 9Schneider children's medical center of ISrael, Petah Tikva, Israel, 10Schneider Children's Medical Cenetr of Israel, Tel Aviv University, JERUSALEM, Israel

    Background/Purpose: Fever of Unknown Origin (FUO) is a relatively common clinical challenge that is frequently referred for evaluation by pediatric rheumatologists. In many cases, it…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 62
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology